Skip to main content

ISOP ACoP 2025 Annual Conference Main banner

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

C
S-031
Case Study: Integrating ADPPK CDISC Standards into Pharmacometric Programming and Analysis Workflows

Favorite
M-099
Case Study: Parameter Estimation of an NLME-QSP Model

Favorite
M-113
Characterization of PK Characteristics of IMMUNORHO after Intramuscular Administration for the Prevention of RhD Isoimmunisation in Rh(D) Negative Women Pregnant with Rh(D) Positive Fetuses: Population Pharmacokinetic Approach

Favorite
T-105
Characterizing Chimeric Aducanumab Disposition in a Preclinical Alzheimer’s Model Using Population PK Modeling

Favorite
T-059
Characterizing the Exposure–Response Relationship of MK-2060 in Participants with End Stage Kidney Disease Receiving Hemodialysis

Favorite
M-003
Characterizing the pharmacokinetics of MAM01, an extended half-life monoclonal antibody for the prevention of malaria using a population approach

Favorite
S-106
Clinical PK characterization of EGT710, a novel coronavirus Mpro inhibitor, and simulation of target attainment rates for efficacious dose prediction

Favorite
T-060
Clinical Utility Index Leveraging Results From Clinical Trial Simulation for Safety and Efficacy Outcomes Derived From Longitudinal Models

Favorite
M-078
Combining Mechanistic Modeling and Deep Learning for Predicting Survival Probabilities in Oncology

Favorite
M-017
Comparative Sensitivity Analysis of Semi-mechanistic and QSP Models of Humoral Response Following Vaccination

Favorite
M-104
Comparison of $PRED and $DES in NONMEM for time-varying categorical covariates in disease progression modeling.

Favorite
T-020
Comparison of Machine Learning and traditional Population Pharmacokinetic of Gabapentin in Neuropathic Pain

Favorite
T-077
Comparison of Population Pharmacokinetic Platforms, Monolix and Phoenix for Cephalexin in Infants

Favorite
T-101
Comparison of Predictive Performance of Complex IS/ID and Simple KPD Models on durability projections of Neutralizing Antibodies of LNP-mRNA-Based Vaccines

Favorite
S-054
Computer Modeling of Bevacizumab Drug Distribution After Intravitreal Injection in Rabbit and Human Eyes

Favorite
T-002
Concentration-QTc modeling for ponsegromab using pooled data from 3 phase 1 studies in healthy participants

Favorite
S-058
Concentration-QTcF Analysis Indicates Casdatifan Does Not Prolong QTcF

Favorite
T-018
Constrained Multi-Objective optimization population PK model selection in NLME and RDarwin.

Favorite
M-018
Construction of a Whole-Body Physiologically Based Pharmacokinetic (PBPK) Model to Facilitate the Design of LNP based mRNA Therapeutics for Secreted Protein Targets with Applications to Anti-Viral Therapies

Favorite
T-004
Continuous infusion simulations in PBPK and QSP models reveal steady-state properties and rate-limiting steps.

Favorite